Does EEG predict response to valproate versus lithium in patients with mania?

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Neurology

Background:

• Predicting patient response to mood stabilizers like lithium and valproate in mania is challenging.
• Electroencephalogram (EEG) abnormalities may offer insights into treatment efficacy.

Purpose of the Study:

• To investigate the association between nonepileptiform EEG abnormalities and response to valproate versus lithium in patients with mania.
• To determine if EEG patterns can predict differential medication response.

Main Methods:

• Retrospective analysis of patients with mania who responded to either lithium or valproate.
• Categorization of patients based on EEG findings, specifically nonepileptiform abnormalities.
• Statistical comparison of EEG abnormalities in lithium-responders versus valproate-responders.

Main Results:

• Nonepileptiform EEG abnormalities were present in 30% of lithium responders (not valproate) and 70% of valproate responders (not lithium).
• Patients with mania and EEG abnormalities, especially sharp activity, showed a statistically significant higher likelihood of responding to valproate compared to lithium (chi2 = 4.9, df = 1, p = .027).

Conclusions:

• Nonepileptiform EEG abnormalities, particularly sharp activity, may serve as a biomarker for predicting valproate response over lithium in patients with mania.
• Further research is needed to confirm these findings and explore their applicability to other anticonvulsant treatments for mania.